BRIEF published on 11/08/2024 at 07:05, 1 year 7 months ago Innate Pharma presents its innovations in oncology at SITC 2024 Immunotherapy Innate Pharma SITC 2024 NK Cell Engage Antibody-drug Conjugate
PRESS RELEASE published on 11/08/2024 at 07:00, 1 year 7 months ago Inside Information / Other news releases Innate Pharma announces new preclinical data on IPH6501 and IPH4502 to be presented at SITC Annual Meeting 2024. Advances in immunotherapy reflected in drug development progress Drug Development Preclinical Data Immunotherapy Innate Pharma SITC Annual Meeting 2024
BRIEF published on 06/17/2024 at 07:05, 2 years ago Innate Pharma reveals promising results for SAR443579/IPH6101 in blood cancers Sanofi Innate Pharma SAR443579 Leukemia Blood Cancer
PRESS RELEASE published on 06/17/2024 at 07:00, 2 years ago Inside Information / Other news releases Innate Pharma shares updated results from the Sanofi developed blood cancer Phase 1/2 SAR443579/IPH6101 trial, showing promising clinical efficacy and safety in patients with R/R AML Sanofi Innate Pharma Blood Cancer NK Cell Engager Phase 1/2 Trial
BRIEF published on 05/28/2024 at 07:05, 2 years ago Innate Pharma announces its participation in upcoming investor conferences Biotechnology Investor Conferences Immunotherapy Health Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 2 years 1 month ago Results of the Combined General Meeting of Innate Pharma Voting Results Supervisory Board General Assembly Innate Pharma
PRESS RELEASE published on 05/23/2024 at 22:00, 2 years 1 month ago Inside Information / Other news releases Innate Pharma announces the voting results of its 2024 AGM. Quorum at 44.92%. Re-election of two Supervisory Board members. Details available on company's website Voting Results Supervisory Board Quorum 2024 AGM Innate Pharma
BRIEF published on 05/21/2024 at 07:05, 2 years 1 month ago Clarification on the status of SAR443579 treatment by Innate Pharma FDA Sanofi Innate Pharma SAR443579 Fast Track
Published on 06/24/2026 at 03:15, 6 hours 19 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 9 hours 34 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 9 hours 49 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 10 hours 14 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 10 hours 19 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 09:00, 34 minutes ago Yellow Card Can Now Offer Regulated Virtual Asset and Related Services from Switzerland
Published on 06/24/2026 at 08:58, 36 minutes ago GEVELOT S.A.: Number of shares and voting rights in the Company 23 June 2026
Published on 06/24/2026 at 08:39, 55 minutes ago Sirma and Schwarz Digits Forge Strategic Alliance to Advance Sovereign Enterprise AI Across Europe
Published on 06/23/2026 at 19:47, 13 hours 47 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 14 hours 24 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 16:47, 16 hours 47 minutes ago Statement of transactions in own shares from June 15, 2026 to June 19, 2026
Published on 06/23/2026 at 15:44, 17 hours 50 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 19 hours 34 minutes ago Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada
